Cargando…

Uveal Melanoma Metastasis

SIMPLE SUMMARY: Survival after diagnosis of metastatic uveal melanoma has not significantly improved over decades, most patients die within a year from diagnosis. Uveal melanoma is clearly distinct from cutaneous melanoma and the therapies developed for the latter do not work for the former. This is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossi, Ernesto, Croce, Michela, Reggiani, Francesco, Schinzari, Giovanni, Ambrosio, Marianna, Gangemi, Rosaria, Tortora, Giampaolo, Pfeffer, Ulrich, Amaro, Adriana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616038/ https://www.ncbi.nlm.nih.gov/pubmed/34830841 http://dx.doi.org/10.3390/cancers13225684

Ejemplares similares

Interdependence of Molecular Lesions That Drive Uveal Melanoma Metastasis
por: Reggiani, Francesco, et al.
Publicado: (2023)

How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma
por: Marseglia, Mariarosaria, et al.
Publicado: (2021)

Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives
por: Croce, Michela, et al.
Publicado: (2019)

The biology of uveal melanoma
por: Amaro, Adriana, et al.
Publicado: (2017)

Cerivastatin Synergizes with Trametinib and Enhances Its Efficacy in the Therapy of Uveal Melanoma
por: Amaro, Adriana Agnese, et al.
Publicado: (2023)

Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?
por: Rossi, Ernesto, et al.
Publicado: (2019)

Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients
por: Rossi, Ernesto, et al.
Publicado: (2023)

Pembrolizumab as first-line treatment for metastatic uveal melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019)

Potential Onco-Suppressive Role of miR122 and miR144 in Uveal Melanoma through ADAM10 and C-Met Inhibition
por: Amaro, Adriana, et al.
Publicado: (2020)

Data Fusion Techniques for the Integration of Multi-Domain Genomic Data from Uveal Melanoma
por: Pfeffer, Max, et al.
Publicado: (2019)

Uveal Melanoma
por: Pfeffer, Ulrich
Publicado: (2019)

Evaluation and Comparison of Multi-Omics Data Integration Methods for Subtyping of Cutaneous Melanoma
por: Amaro, Adriana, et al.
Publicado: (2022)

Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study
por: Rossi, Ernesto, et al.
Publicado: (2022)

Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment
por: Rossi, Ernesto, et al.
Publicado: (2020)

Conjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of Melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019)

Secondary Somatic Mutations in G-Protein-Related Pathways and Mutation Signatures in Uveal Melanoma
por: Piaggio, Francesca, et al.
Publicado: (2019)

“Skin rashes” and immunotherapy in melanoma: distinct dermatologic adverse events and implications for therapeutic management
por: Sollena, Pietro, et al.
Publicado: (2021)

Mda-9/Syntenin Is Expressed in Uveal Melanoma and Correlates with Metastatic Progression
por: Gangemi, Rosaria, et al.
Publicado: (2012)

Uveal Melanoma Metastasis to the Thyroid
por: Thanadar, Rokshana R., et al.
Publicado: (2023)

The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer
por: Cianci, Rossella, et al.
Publicado: (2019)

Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma
por: Rossi, Ernesto, et al.
Publicado: (2023)

Uveal Melanoma
por: Papastefanou, Vasilios P., et al.
Publicado: (2011)

Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019)

Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells
por: Amaro, Adriana, et al.
Publicado: (2023)

Efficacy of immune checkpoint inhibitors in different types of melanoma
por: Rossi, Ernesto, et al.
Publicado: (2020)

Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study
por: Rossi, Ernesto, et al.
Publicado: (2023)

Tissue-Based Microarray Expression of Genes Predictive of Metastasis in Uveal Melanoma and Differentially Expressed in Metastatic Uveal Melanoma
por: Demirci, Hakan, et al.
Publicado: (2013)

Expression of the Metastasis Suppressor KAI1 in Uveal Melanoma
por: Maloney, Shawn C., et al.
Publicado: (2013)

Expression of the metastasis suppressor BRMS1 in uveal melanoma
por: Ventura, Bruna V, et al.
Publicado: (2014)

Low Level of PALMD Contributes to the Metastasis of Uveal Melanoma
por: Cai, Min-Yun, et al.
Publicado: (2022)

Nomogram of uveal melanoma as prediction model of metastasis risk
por: Wang, Yimin, et al.
Publicado: (2023)

Role of Epigenetics in Uveal Melanoma
por: Li, Yongyun, et al.
Publicado: (2017)

Spliceosome Mutations in Uveal Melanoma
por: Nguyen, Josephine Q.N., et al.
Publicado: (2020)

Differential Expression of DNA Repair Genes in Prognostically-Favorable versus Unfavorable Uveal Melanoma
por: Dogrusöz, Mehmet, et al.
Publicado: (2019)

Identification of histone deacetylase inhibitors with (arylidene)aminoxy scaffold active in uveal melanoma cell lines
por: Nencetti, Susanna, et al.
Publicado: (2020)

DNA Methylation and Uveal Melanoma
por: Yang, Zhi-Kun, et al.
Publicado: (2018)

Applying Single-Cell Technology in Uveal Melanomas: Current Trends and Perspectives for Improving Uveal Melanoma Metastasis Surveillance and Tumor Profiling
por: Wang, Mona Meng, et al.
Publicado: (2021)

Proteomics of Primary Uveal Melanoma: Insights into Metastasis and Protein Biomarkers
por: Jang, Geeng-Fu, et al.
Publicado: (2021)

The genetics of uveal melanoma: current insights
por: Helgadottir, Hildur, et al.
Publicado: (2016)

Uveal Melanoma Biopsy: A Review
por: Frizziero, Luisa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2f7f057cnsptaqms2lqo0226oh